Logo Light ModeLogo Dark Mode
Why Subscribe?About UsAccreditationLearning Hub CentralLive EventsBlog

Learning Hub Central

Loading…

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure

Learning Hub Central

Filter by title, faculty, or specialty to find the course you're looking for.

SpecialtySolid Tumor(15 courses)
All specialties

Solid Tumor

15 courses

2026 MCM | Applications of MRD Concept in Solid Tumors

2026 MCM | Applications of MRD Concept in Solid Tumors

0.00 Credits
1 Chapter
Solid Tumor
Free
2026 MCM | What Do You Need to Know About ADC Toxicity in Solid Tumors? Most Common Adverse Events

2026 MCM | What Do You Need to Know About ADC Toxicity in Solid Tumors? Most Common Adverse Events

0.00 Credits
1 Chapter
Solid Tumor
Free
2025 CCC | Antibody Drug Conjugates in Solid Tumors

2025 CCC | Antibody Drug Conjugates in Solid Tumors

0.00 Credits
1 Chapter
Solid Tumor
Free
2025 CCC | Targeting Primary CNS Tumors

2025 CCC | Targeting Primary CNS Tumors

0.00 Credits
1 Chapter
Solid Tumor
Free
Gene Therapies and Immunotherapy Updates in Solid Tumor Malignancies

Gene Therapies and Immunotherapy Updates in Solid Tumor Malignancies

0.00 Credits
1 Chapter
Solid Tumor
Free
Predictive and Prognostic Biomarkers for IO: Value of TMB, MSI, PD-L1, and Others in Liquid and Solid Tumor Specimens

Predictive and Prognostic Biomarkers for IO: Value of TMB, MSI, PD-L1, and Others in Liquid and Solid Tumor Specimens

0.00 Credits
1 Chapter
Solid Tumor
Free
2021 WCS | Solid Tumors: Gynecology, Prostate & GI Malignancies

2021 WCS | Solid Tumors: Gynecology, Prostate & GI Malignancies

0.00 Credits
1 Chapter
Solid Tumor
Free
Targeting RAS-RAF-MAPK Pathway

Targeting RAS-RAF-MAPK Pathway

0.00 Credits
1 Chapter
Solid Tumor
Free
Agnostic Tumor Drug Development

Agnostic Tumor Drug Development

0.00 Credits
1 Chapter
Solid Tumor
Free
Cancer Survivorship: What are the Currents Standards of Care in Solid Tumors

Cancer Survivorship: What are the Currents Standards of Care in Solid Tumors

0.00 Credits
1 Chapter
Solid Tumor
Free
Management of Immunotherapy Related Adverse Events in Solid Tumors

Management of Immunotherapy Related Adverse Events in Solid Tumors

0.00 Credits
1 Chapter
Solid Tumor
Free
Solid Tumor Oncology

Solid Tumor Oncology

0.00 Credits
1 Chapter
Solid Tumor
Free
Advances in Non-PD(L)1 Immunotherapies in Solid Tumors

Advances in Non-PD(L)1 Immunotherapies in Solid Tumors

0.00 Credits
1 Chapter
Solid Tumor
Free
2024 SPS Seattle | Clinical Update: Solid Organ Tumors

2024 SPS Seattle | Clinical Update: Solid Organ Tumors

0.00 Credits
1 Chapter
Solid Tumor
Free
Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

0.00 Credits
1 Chapter
Solid Tumor
Free

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure